Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ramosetron

Known as: 5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1H-benzimidazol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND & AIMS Ramosetron, a serotonin (5-hydroxytryptamine)-3 receptor antagonist with high selectivity, reduced stress… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Review
2013
Review
2013
Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
2013
2013
Chemotherapeutic agents, including 5‐fluorouracil (5‐FU), frequently cause intestinal mucositis resulting in severe diarrhoea and… Expand
2012
2012
Background The purpose of this study was to evaluate the effect of an aprepitant, neurokinin-1(NK1) receptor antagonist, for… Expand
  • table 1
  • table 2
  • table 4
  • table 3
  • table 5
Highly Cited
2009
Highly Cited
2009
BACKGROUND Ramosetron is a new selective 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonist that reportedly has more potent… Expand
  • table 2
  • table 3
  • table 1
Highly Cited
2009
Highly Cited
2009
BackgroundPatients undergoing general anesthesia for laparoscopic cholecystectomy are at high risk for postoperative nausea and… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2008
Highly Cited
2008
Study Design. A prospective, randomized, double-blind clinical trial. Objective. To compare the effect of ramosetron with that of… Expand
Review
2002
Review
2002
Ramosetron is a selective serotonin 5-HT3 receptor antagonist with an affinity higher than that of the previously available drugs… Expand
Highly Cited
2000
Highly Cited
2000
UNLABELLED In a prospective, randomized, double-blinded, placebo-controlled trial, we evaluated the efficacy of ramosetron at… Expand
1999
1999
UNLABELLED In a prospective, randomized, double-blinded study, we evaluated the efficacy of granisetron and ramosetron for… Expand